Drug Profile
LY 223982
Alternative Names: CGS 23131; SKF 107324Latest Information Update: 29 Aug 1997
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Antiasthmatics; Antipsoriatics; Benzophenones
- Mechanism of Action Leukotriene B4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma; Psoriasis; Rheumatic disorders
Most Recent Events
- 29 Aug 1997 Discontinued-II for Psoriasis in USA (Unknown route)